US Stock MarketDetailed Quotes
HLVX HilleVax
- 1.980
- +0.040+2.06%
Close Dec 30 16:00 ET
- 1.930
- -0.050-2.53%
Post 20:01 ET
98.62MMarket Cap-0.64P/E (TTM)
2.010High1.890Low392.87KVolume1.910Open1.940Pre Close771.31KTurnover1.31%Turnover RatioLossP/E (Static)49.81MShares20.22052wk High0.54P/B59.24MFloat Cap1.55052wk Low--Dividend TTM29.92MShs Float24.420Historical High--Div YieldTTM6.19%Amplitude1.550Historical Low1.963Avg Price1Lot Size
Heat List
US
Overall
Symbol
Price
% Chg
No Data
HilleVax Stock Forum
📊⚡️📊
On a day that saw its stock plummet by 84%, closing at $2.25, HilleVax, Inc. (Nasdaq: HLVX) announced the topline data results from its NEST-IN1 clinical study. This notable decline followed the announcement that the NEST-IN1 study did not meet its primary or secondary efficacy endpoints, leading the company to discontinue further dev...
HilleVax Reports Topline Data from NEST-IN1 Phase 2b Clinical Study of HIL-214 in Infants
HilleVax announced topline results from the NEST-IN1 Phase 2b study of HIL-214 in infants. The trial, conducted in the US and Latin America, did not meet its primary or secondary efficacy endpoints. Specifically, the vaccine showed a mere 5% efficacy against moderate or severe acute gastroenteritis caused by norovirus, which was statistically insignificant. Consequently, HilleVax wil...
No comment yet